Drug Profile


Alternative Names: O 861T

Latest Information Update: 18 Jun 2001

Price : $50

At a glance

  • Originator Harvard University; Massachusetts Institute of Technology; Organix
  • Class Organotechnetium compounds; Radiopharmaceutical diagnostics; Radiopharmaceuticals; Tropanes
  • Mechanism of Action Single-photon emission-computed tomography enhancers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Neurological disorders

Most Recent Events

  • 18 Jun 2001 No development reported - Preclinical for Neurological disorders diagnosis in USA (IV)
  • 21 Jul 1997 Preclinical development for Neurological disorders diagnosis in USA (IV)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top